US 7037680
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
expired A61KA61K39/00A61K39/08
Quick answer
US patent 7037680 (Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy) held by The United States of America as represented by the Secretary of the Army expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K39/00, A61K39/08